WCG Achieves ISO 9001 Re-certification: Commitment to Excellence in Clinical Research
WCG, recognized as a leading provider of clinical research solutions, proudly announced the successful completion of its latest ISO 9001 audit. This recent achievement underscores the effectiveness of WCG's Quality Management System (QMS), which plays a crucial role in guaranteeing high standards across its global services and operations in clinical research.
ISO 9001 is a universally acknowledged standard that aims to ensure organizations consistently meet customer and regulatory requirements while fostering continuous improvement and informed decision-making. The successful completion of this audit showcases WCG's robust quality framework, which supports a vast array of clinical research services, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) services, as well as initiatives such as data monitoring committees, statistical analysis, recruitment, safety reporting, and overall trial management solutions. This wide-ranging service portfolio reflects WCG's pivotal role as a dependable partner in quality assurance within the realm of clinical research.
Sam Srivastava, CEO of WCG, remarked on the significance of this accomplishment: "This audit validates the strength and scalability of our world-class quality management system across WCG. This system is crafted not just for IRB and IBC operations but has the flexibility to cater to an expansive portfolio. The integrity and participant protection we guarantee in our IRB and IBC services extend to deliver consistency and reliability across all our clinical research solutions for a variety of stakeholders, including sponsors, CROs, sites, and research teams globally."
It is noteworthy that WCG's IRB made history in 2010 as the first IRB worldwide to obtain ISO 9001 certification. The company continues to set high standards for quality across its entire suite of services.
David Forster, the Chief Compliance Officer at WCG, elaborated on the audit's significance: "ISO 9001 audits evaluate how well quality principles are integrated into daily operations, not merely how they are documented. This successful audit is indicative of disciplined practices, solid governance, and risk-based decision-making that permeates our IRB, IBC, and operational support services. It confirms our ability to consistently scale quality in alignment with the evolving workflows in clinical research."
Achieving and maintaining ISO 9001 certification requires ongoing oversight through regular audits. WCG’s successful audit reinforces a shared commitment to a quality culture throughout the organization. This not only fortifies the foundation for its IRB and IBC services but also establishes WCG's stature as a global leader in high-integrity clinical research solutions.
About WCG:
WCG serves as the decision-making infrastructure for clinical research, blending reliable oversight with smart technologies that enhance judgment and mitigate risk throughout the trial lifecycle. With decades of experience and access to the industry's most comprehensive dataset, WCG empowers research teams to make confident decisions, facilitating advancement in therapies across various development phases. For more details, please visit wcgclinical.com or follow WCG on LinkedIn.
ISO 9001 is a universally acknowledged standard that aims to ensure organizations consistently meet customer and regulatory requirements while fostering continuous improvement and informed decision-making. The successful completion of this audit showcases WCG's robust quality framework, which supports a vast array of clinical research services, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) services, as well as initiatives such as data monitoring committees, statistical analysis, recruitment, safety reporting, and overall trial management solutions. This wide-ranging service portfolio reflects WCG's pivotal role as a dependable partner in quality assurance within the realm of clinical research.
Sam Srivastava, CEO of WCG, remarked on the significance of this accomplishment: "This audit validates the strength and scalability of our world-class quality management system across WCG. This system is crafted not just for IRB and IBC operations but has the flexibility to cater to an expansive portfolio. The integrity and participant protection we guarantee in our IRB and IBC services extend to deliver consistency and reliability across all our clinical research solutions for a variety of stakeholders, including sponsors, CROs, sites, and research teams globally."
It is noteworthy that WCG's IRB made history in 2010 as the first IRB worldwide to obtain ISO 9001 certification. The company continues to set high standards for quality across its entire suite of services.
David Forster, the Chief Compliance Officer at WCG, elaborated on the audit's significance: "ISO 9001 audits evaluate how well quality principles are integrated into daily operations, not merely how they are documented. This successful audit is indicative of disciplined practices, solid governance, and risk-based decision-making that permeates our IRB, IBC, and operational support services. It confirms our ability to consistently scale quality in alignment with the evolving workflows in clinical research."
Achieving and maintaining ISO 9001 certification requires ongoing oversight through regular audits. WCG’s successful audit reinforces a shared commitment to a quality culture throughout the organization. This not only fortifies the foundation for its IRB and IBC services but also establishes WCG's stature as a global leader in high-integrity clinical research solutions.
About WCG:
WCG serves as the decision-making infrastructure for clinical research, blending reliable oversight with smart technologies that enhance judgment and mitigate risk throughout the trial lifecycle. With decades of experience and access to the industry's most comprehensive dataset, WCG empowers research teams to make confident decisions, facilitating advancement in therapies across various development phases. For more details, please visit wcgclinical.com or follow WCG on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.